These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34933729)

  • 41. The relationship between papillary thyroid carcinoma and preoperative TSH level: A cross-sectional study from Syria.
    Shahrokh M; Alsultan M; Kabalan Y
    Medicine (Baltimore); 2023 Jul; 102(28):e34283. PubMed ID: 37443517
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
    Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
    Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The T4/T3 quotient as a risk factor for differentiated thyroid cancer: a case control study.
    Sasson M; Kay-Rivest E; Shoukrun R; Florea A; Hier M; Forest VI; Tamilia M; Payne RJ
    J Otolaryngol Head Neck Surg; 2017 Apr; 46(1):28. PubMed ID: 28376913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease.
    Fiore E; Vitti P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1134-45. PubMed ID: 22278420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
    Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
    Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules.
    Polyzos SA; Kita M; Efstathiadou Z; Poulakos P; Slavakis A; Sofianou D; Flaris N; Leontsini M; Kourtis A; Avramidis A
    J Cancer Res Clin Oncol; 2008 Sep; 134(9):953-60. PubMed ID: 18327610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thyroglobulin antibodies as a potential predictive marker of papillary thyroid carcinoma in patients with indeterminate cytology.
    Karatzas T; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Boutzios G
    Am J Surg; 2016 Nov; 212(5):946-952. PubMed ID: 27324384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules.
    Shi L; Li Y; Guan H; Li C; Shi L; Shan Z; Teng W
    Endocr J; 2012; 59(11):973-80. PubMed ID: 22785429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Focal Lymphocytic Thyroiditis Nodules Share the Features of Papillary Thyroid Cancer on Ultrasound.
    Hwang S; Shin DY; Kim EK; Yang WI; Byun JW; Lee SJ; Kim G; Im SJ; Lee EJ
    Yonsei Med J; 2015 Sep; 56(5):1338-44. PubMed ID: 26256977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyroglobulin Changes are Highly Dependent on TSH in Low-risk DTC Patients not Treated with Radioiodine.
    Matrone A; Faranda A; Latrofa F; Gambale C; Stefani Donati D; Molinaro E; Agate L; Viola D; Piaggi P; Torregrossa L; Basolo F; Elisei R
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32453405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease.
    Jin J; Machekano R; McHenry CR
    Am J Surg; 2010 Mar; 199(3):294-7; discussion 298. PubMed ID: 20226898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Higher TSH level is a risk factor for differentiated thyroid cancer.
    Kim HK; Yoon JH; Kim SJ; Cho JS; Kweon SS; Kang HC
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):472-7. PubMed ID: 22924613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
    Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels.
    Kim H; Jung J; Cho YS; Choi JY; Park H; Lee YB; Kim SW; Chung JH; Kim TH
    Sci Rep; 2021 Nov; 11(1):22322. PubMed ID: 34785735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer.
    Jonklaas J; Nsouli-Maktabi H; Soldin SJ
    Thyroid; 2008 Sep; 18(9):943-52. PubMed ID: 18788918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can preoperative serum thyroglobulin levels predict the risk of malignancy? Results from prospective analysis of biochemical predictors of malignancy in thyroid nodules.
    Hulikal N; Re A; Banoth M; Chowhan AK; Yutla M; Sachan A
    Acta Otorhinolaryngol Ital; 2020 Feb; 40(1):33-37. PubMed ID: 32275647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oncofetal fibronectin mRNA is highly abundant in the blood of patients with papillary thyroid carcinoma and correlates with high-serum thyroid-stimulating hormone levels.
    Wehmeier M; Petrich T; Brand K; Lichtinghagen R; Hesse E
    Thyroid; 2010 Jun; 20(6):607-13. PubMed ID: 20470202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RISK FACTORS FOR NONREMISSION AND PROGRESSION-FREE SURVIVAL AFTER I-131 THERAPY IN PATIENTS WITH LUNG METASTASIS FROM DIFFERENTIATED THYROID CANCER: A SINGLE-INSTITUTE, RETROSPECTIVE ANALYSIS IN SOUTHERN CHINA.
    Chen P; Feng HJ; Ouyang W; Wu JQ; Wang J; Sun YG; Xian JL; Huang LH
    Endocr Pract; 2016 Sep; 22(9):1048-56. PubMed ID: 27124694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Higher TSH Is Not Associated With Thyroid Cancer Risk in the Presence of Thyroid Autoimmunity.
    Paparodis RD; Bantouna D; Karvounis E; Imam S; Jaume JC
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32391913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Functional activity of autonomous adenoma in Germany].
    Graf D; Helmich-Kapp B; Graf S; Veit F; Lehmann N; Mann K
    Dtsch Med Wochenschr; 2012 Oct; 137(41):2089-92. PubMed ID: 23033166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.